Cyclosporine concentrations in blood after liver transplantation: Correlation of immunoassay results with clinical events

M. C. Haven, L. M. Sobeski, R. A. Earl, Rodney Smith Markin

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

To investigate the clinical utility of immunoassays for cyclosporine and metabolites in plasma and whole blood, we monitored 25 patients after orthotopic liver transplantation. We compared cyclosporine as measured by TDx fluorescence polarization immunoassay (of both plasma and whole blood) and by two polyclonal radioimmunoassays (from Sandoz and INCSTAR). We found considerable differences in measured cyclosporine concentrations, which were dependent on method, matrix, and clinical condition. Correlation coefficients between results by the various methods for samples from individual patients ranged from 0.825 to 0.996. The three methods used for monitoring cyclosporine in whole blood gave proportional results (Sandoz < INCSTAR < TDx) in individual patients, but results for the two methods for plasma sometimes differed by more than 100%. In some cases, ratios of plasma cyclosporine concentration (result by TDx/result by Sandoz) were correlated with disturbances in hepatic excretory function or kidney function. This ratio may be useful in monitoring for nephrotoxicity.

Original languageEnglish (US)
Pages (from-to)564-568
Number of pages5
JournalClinical Chemistry
Volume35
Issue number4
StatePublished - Jan 1 1989

Fingerprint

Immunoassay
Liver
Liver Transplantation
Cyclosporine
Blood
Plasmas
Fluorescence Polarization Immunoassay
Monitoring
Metabolites
Radioimmunoassay
Fluorescence
Polarization
Kidney

ASJC Scopus subject areas

  • Clinical Biochemistry

Cite this

Cyclosporine concentrations in blood after liver transplantation : Correlation of immunoassay results with clinical events. / Haven, M. C.; Sobeski, L. M.; Earl, R. A.; Markin, Rodney Smith.

In: Clinical Chemistry, Vol. 35, No. 4, 01.01.1989, p. 564-568.

Research output: Contribution to journalArticle

@article{056f53394e574d9cb927c7f32fe26303,
title = "Cyclosporine concentrations in blood after liver transplantation: Correlation of immunoassay results with clinical events",
abstract = "To investigate the clinical utility of immunoassays for cyclosporine and metabolites in plasma and whole blood, we monitored 25 patients after orthotopic liver transplantation. We compared cyclosporine as measured by TDx fluorescence polarization immunoassay (of both plasma and whole blood) and by two polyclonal radioimmunoassays (from Sandoz and INCSTAR). We found considerable differences in measured cyclosporine concentrations, which were dependent on method, matrix, and clinical condition. Correlation coefficients between results by the various methods for samples from individual patients ranged from 0.825 to 0.996. The three methods used for monitoring cyclosporine in whole blood gave proportional results (Sandoz < INCSTAR < TDx) in individual patients, but results for the two methods for plasma sometimes differed by more than 100{\%}. In some cases, ratios of plasma cyclosporine concentration (result by TDx/result by Sandoz) were correlated with disturbances in hepatic excretory function or kidney function. This ratio may be useful in monitoring for nephrotoxicity.",
author = "Haven, {M. C.} and Sobeski, {L. M.} and Earl, {R. A.} and Markin, {Rodney Smith}",
year = "1989",
month = "1",
day = "1",
language = "English (US)",
volume = "35",
pages = "564--568",
journal = "Clinical Chemistry",
issn = "0009-9147",
publisher = "American Association for Clinical Chemistry Inc.",
number = "4",

}

TY - JOUR

T1 - Cyclosporine concentrations in blood after liver transplantation

T2 - Correlation of immunoassay results with clinical events

AU - Haven, M. C.

AU - Sobeski, L. M.

AU - Earl, R. A.

AU - Markin, Rodney Smith

PY - 1989/1/1

Y1 - 1989/1/1

N2 - To investigate the clinical utility of immunoassays for cyclosporine and metabolites in plasma and whole blood, we monitored 25 patients after orthotopic liver transplantation. We compared cyclosporine as measured by TDx fluorescence polarization immunoassay (of both plasma and whole blood) and by two polyclonal radioimmunoassays (from Sandoz and INCSTAR). We found considerable differences in measured cyclosporine concentrations, which were dependent on method, matrix, and clinical condition. Correlation coefficients between results by the various methods for samples from individual patients ranged from 0.825 to 0.996. The three methods used for monitoring cyclosporine in whole blood gave proportional results (Sandoz < INCSTAR < TDx) in individual patients, but results for the two methods for plasma sometimes differed by more than 100%. In some cases, ratios of plasma cyclosporine concentration (result by TDx/result by Sandoz) were correlated with disturbances in hepatic excretory function or kidney function. This ratio may be useful in monitoring for nephrotoxicity.

AB - To investigate the clinical utility of immunoassays for cyclosporine and metabolites in plasma and whole blood, we monitored 25 patients after orthotopic liver transplantation. We compared cyclosporine as measured by TDx fluorescence polarization immunoassay (of both plasma and whole blood) and by two polyclonal radioimmunoassays (from Sandoz and INCSTAR). We found considerable differences in measured cyclosporine concentrations, which were dependent on method, matrix, and clinical condition. Correlation coefficients between results by the various methods for samples from individual patients ranged from 0.825 to 0.996. The three methods used for monitoring cyclosporine in whole blood gave proportional results (Sandoz < INCSTAR < TDx) in individual patients, but results for the two methods for plasma sometimes differed by more than 100%. In some cases, ratios of plasma cyclosporine concentration (result by TDx/result by Sandoz) were correlated with disturbances in hepatic excretory function or kidney function. This ratio may be useful in monitoring for nephrotoxicity.

UR - http://www.scopus.com/inward/record.url?scp=0024603794&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024603794&partnerID=8YFLogxK

M3 - Article

C2 - 2649273

AN - SCOPUS:0024603794

VL - 35

SP - 564

EP - 568

JO - Clinical Chemistry

JF - Clinical Chemistry

SN - 0009-9147

IS - 4

ER -